Obama doesn’t care about government waste and abuse. If you need proof, here it is. He canceled Obamacare’s fraud audit program because of budget restraints. Fraud audits can sometimes justify their existence by saving the government more money than they cost.
For him to cancel this means he doesn’t care who is using or abusing the system.
Facing major budget and staff cuts, federal officials are scaling back several high-profile health-care fraud and abuse investigations, including an audit of the state insurance exchanges that are set to open later this year as a key provision of the Affordable Care Act.
- A planned audit into computer security at state marketplaces — known as exchanges — that will sell individual health-
insurance policies under the health-care law. The inspector general’s office said that “time pressures” to get the exchanges running by Oct. 1 may increase risks that states will fail to shield private medical information from “hacker exploits, unauthorized data access and data theft or manipulation.” In addition, the OIG document said, about $3.8 billion in grant money to develop the exchanges is “potentially at risk for wasteful spending.” Seventeen states are planning to run their own exchanges, while the rest will be operated by the federal government or in state-federal partnerships.
- An investigation to determine if nursing homes overuse antipsychotic drugs in treating the elderly and which of these drugs are prescribed most often. The canceled initiative was supposed to identify nursing homes that failed to follow federal rules requiring that patients “be free from unnecessary drugs.”
- A probe into how well state governments and Medicaid-
managed care groups ferret out fraud and abuse. Medicaid health plans collect more than $100 billion in tax dollars annually for serving about 30 million low-
income people and are set to add millions of new members under the health-care law.
- A review of drugs marketed under Medicare Part D without first being approved by the Food and Drug Administration for safety and effectiveness. Medicare paid more than $3 billion from 2006 through 2010 for these products, but officials said they are abandoning plans to recover money improperly paid to drug companies.
- A study of crooked suppliers of durable medical equipment, such as wheelchairs and other medical devices used in the home, who manage to stay in business even after federal officials revoke their billing privileges. The durable medical equipment market has long been troubled by questionable expenditures. The audit was to target merchants in South Florida, a hotbed of Medicare and Medicaid fraud.